IT1229477B - Impiego di 5' deossi - 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative - Google Patents

Impiego di 5' deossi - 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative

Info

Publication number
IT1229477B
IT1229477B IT8919737A IT1973789A IT1229477B IT 1229477 B IT1229477 B IT 1229477B IT 8919737 A IT8919737 A IT 8919737A IT 1973789 A IT1973789 A IT 1973789A IT 1229477 B IT1229477 B IT 1229477B
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
methylthioadenosine
deoxy
preparation
salts
Prior art date
Application number
IT8919737A
Other languages
English (en)
Other versions
IT8919737A0 (it
Inventor
Emanuela Maggioni Moratti
Original Assignee
Bioresearch Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch Spa filed Critical Bioresearch Spa
Publication of IT8919737A0 publication Critical patent/IT8919737A0/it
Priority to IT8919737A priority Critical patent/IT1229477B/it
Priority to AT90104640T priority patent/ATE99945T1/de
Priority to ES90104640T priority patent/ES2062137T3/es
Priority to EP90104640A priority patent/EP0387756B1/en
Priority to DE90104640T priority patent/DE69005860T2/de
Priority to KR1019900003230A priority patent/KR900013969A/ko
Priority to DK90104640.9T priority patent/DK0387756T3/da
Priority to JP2060126A priority patent/JPH0778011B2/ja
Priority to US07/492,991 priority patent/US5753213A/en
Priority to CA002012046A priority patent/CA2012046C/en
Priority to ZA901929A priority patent/ZA901929B/xx
Application granted granted Critical
Publication of IT1229477B publication Critical patent/IT1229477B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
IT8919737A 1989-03-13 1989-03-13 Impiego di 5' deossi - 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative IT1229477B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT8919737A IT1229477B (it) 1989-03-13 1989-03-13 Impiego di 5' deossi - 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative
DE90104640T DE69005860T2 (de) 1989-03-13 1990-03-12 Verwendung von 5'-Deoxy-5'-methylthioadenosin S-adenosylmethionin und dessen Salzen zur Herstellung von Seborrhea vermindernden Arzneimitteln.
ES90104640T ES2062137T3 (es) 1989-03-13 1990-03-12 Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
EP90104640A EP0387756B1 (en) 1989-03-13 1990-03-12 Use of 5'-deoxy-5'-methylthioadenosine s-adenosylmethionine and their salts in the preparation of seborrhea-reducing pharmaceutical compositions
AT90104640T ATE99945T1 (de) 1989-03-13 1990-03-12 Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln.
KR1019900003230A KR900013969A (ko) 1989-03-13 1990-03-12 지루를 감소시키는 약학 조성물의 제조에 있어서 5'-데옥시-5'-메틸티오아데노신, s-아데노실메티오닌 및 이들의 염의 용도 및 이와 관련된 약학 조성물
DK90104640.9T DK0387756T3 (da) 1989-03-13 1990-03-12 Anvendelse af 5-deoxy-5-methylthioadenosin, S-adenosylmethionin og deres salte ved fremstillingen af seborrhoea-reducerende farmaceutiske præparater
JP2060126A JPH0778011B2 (ja) 1989-03-13 1990-03-13 皮脂漏症を減少させる治療剤
US07/492,991 US5753213A (en) 1989-03-13 1990-03-13 Pharmaceutical compositions containing 5'-deoxy-5'-methylthioadenosine s-adenosylmethionine and their salts for reducing seborrhea
CA002012046A CA2012046C (en) 1989-03-13 1990-03-13 Use of 5'-deoxy-5'-methylthioadenosine, s-adenosylmethionine and their salts for reducing seborrhea
ZA901929A ZA901929B (en) 1989-03-13 1990-03-13 Use of 5'-deoxy-5'-methylthioadenosine,s-adenosylmethionine and their salts in the preparation of seborrhea-reducing pharmaceutical compositions,and the pharmaceutical compositions concerned

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8919737A IT1229477B (it) 1989-03-13 1989-03-13 Impiego di 5' deossi - 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative

Publications (2)

Publication Number Publication Date
IT8919737A0 IT8919737A0 (it) 1989-03-13
IT1229477B true IT1229477B (it) 1991-09-03

Family

ID=11160803

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8919737A IT1229477B (it) 1989-03-13 1989-03-13 Impiego di 5' deossi - 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative

Country Status (11)

Country Link
US (1) US5753213A (it)
EP (1) EP0387756B1 (it)
JP (1) JPH0778011B2 (it)
KR (1) KR900013969A (it)
AT (1) ATE99945T1 (it)
CA (1) CA2012046C (it)
DE (1) DE69005860T2 (it)
DK (1) DK0387756T3 (it)
ES (1) ES2062137T3 (it)
IT (1) IT1229477B (it)
ZA (1) ZA901929B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1247903B (it) * 1991-02-25 1995-01-05 Bioresearch Spa Impiego della s-adenosil-l-metionina nel trattamento della colestasi intraepatica da nutrizione parenterale totale
KR100309141B1 (ko) * 1998-04-13 2001-12-28 조영동 5'-데옥시-5'-메틸티오아데노신을이용한면역분석방법
DE10132338A1 (de) * 2001-07-04 2003-01-16 Basf Ag Verwendung von 5'-Desoxy-5'-methylthioadenosin in hautkosmetischen Mitteln
ITMI20012462A1 (it) * 2001-11-22 2003-05-22 Gnosis Srl Processo per la preparazione di compresse comprendenti s-adenosilmetionina
ITMI20032393A1 (it) * 2003-12-05 2005-06-06 Applied Pharma Res Composizioni contenenti metilioadenosina-mta-e loro uso topico.
US7406746B2 (en) * 2004-08-31 2008-08-05 Bushey Richard D Slider for heavy loads
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
WO2006111541A2 (en) * 2005-04-20 2006-10-26 Basf Plant Science Gmbh Expression cassettes for seed-preferential expression in plants
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
AU2008210327B2 (en) * 2007-01-31 2011-06-16 Methylation Sciences International Srl Extended release pharmaceutical formulations of S-adenosylmethionine
US20100062993A1 (en) * 2008-09-11 2010-03-11 Yochanan R. Bulka Adenosine Nucleotides as Dietary Supplements and as Agents in the Prevention of Cancer and the Metastasis Thereof
US20110027342A1 (en) * 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
WO2014059522A1 (en) 2012-10-17 2014-04-24 Methylation Sciences International Srl Compositions comprising s-adenosylmethionine and a gallic acid ester
WO2014163152A1 (ja) * 2013-04-05 2014-10-09 ライオン株式会社 ノンレム睡眠促進剤、深睡眠促進剤および自然睡眠誘発剤
KR20260020944A (ko) 2023-05-15 2026-02-12 보나파이드 헬스, 엘엘씨 수면 개선 조성물 및 이용 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA7465B (en) * 1973-01-16 1974-11-27 J Voorhees Proliferating skin diseases with acyl derivatives of cyclic adenosine monophosphate
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
US4496588A (en) * 1977-07-11 1985-01-29 Merrell Toraude Et Compagnie Method of treating psoriasis
US4373097A (en) * 1981-04-27 1983-02-08 Bioresearch S.R.L. Process for preparing adenosine derivatives of anti-inflammatory and analgesic activity
IT1137640B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
JPS59134710A (ja) * 1983-01-21 1984-08-02 Suntory Ltd 発酵養毛化粧料
FR2580478B1 (fr) * 1985-04-17 1989-05-12 Christian Chapoton Dispositif de traitement capillaire liberant une substance active et procede de fabrication
EP0216357A3 (en) * 1985-09-25 1988-08-31 Nippon Zeon Co., Ltd. Phosphoramidite compounds and process for production thereof
GB8607265D0 (en) * 1986-03-24 1986-04-30 London King S College Protecting groups of organic synthesis
WO1988004301A1 (fr) * 1986-12-02 1988-06-16 Centre National De La Recherche Scientifique (Cnrs OLIGONUCLEOTIDES alpha
FR2623396B1 (fr) * 1987-11-25 1990-03-30 Sanofi Sa Utilisation de l'ademetionine contre le vieillissement de la peau

Also Published As

Publication number Publication date
ZA901929B (en) 1990-12-28
EP0387756B1 (en) 1994-01-12
DE69005860D1 (de) 1994-02-24
DE69005860T2 (de) 1994-04-28
CA2012046C (en) 2001-02-13
JPH0368520A (ja) 1991-03-25
CA2012046A1 (en) 1990-09-13
IT8919737A0 (it) 1989-03-13
EP0387756A1 (en) 1990-09-19
KR900013969A (ko) 1990-10-22
ES2062137T3 (es) 1994-12-16
ATE99945T1 (de) 1994-01-15
DK0387756T3 (da) 1994-03-07
JPH0778011B2 (ja) 1995-08-23
US5753213A (en) 1998-05-19

Similar Documents

Publication Publication Date Title
IT1229477B (it) Impiego di 5' deossi - 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative
IT8919867A0 (it) Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
IT8919261A0 (it) Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
IT8320301A0 (it) Preparazioni liquide di diidropiridine, procedimento per la loro preparazione cosi' come il loro impiego nella cura delle malattie.
AU1277792A (en) Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts
IT9047999A0 (it) Derivati xantinici 1-7 sostituiti ad attivita' antiasmatica, loro sali fisiologicamente accettabili, loro composizioni farmaceutiche e procedimento per la loro preparazione.
AU8687391A (en) Lithium treatment
ITMI922779A1 (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
IT1229479B (it) Impiego di 5' deossi 5' metiltioadenosina, di s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a favorire la crescita dei capelli in soggetti affetti da calvizie e composizioni farmaceutiche relative.
IT8920358A0 (it) Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale.
IL90959A0 (en) Guanine derivatives,their preparation and pharmaceutical compositions containing them
IT1237509B (it) Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche
ITMI911445A1 (it) Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
CA2135752A1 (en) Use of (E)-2-(p-Fluorophenethyl)-3-Fluoroallylamine in the Treatment of Alzheimer's Disease
AU636876B2 (en) Use of 5'deoxy-5'methylthioadenosine, s-adenosylmethionine and their salts in the preparation of seborrhea-reducing pharmaceutical compositions, and the pharmaceutical compositions concerned
IT1272762B (it) Derivati benz/e/indenici farmaceuticamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT8821879A0 (it) 2 tiolpropionil arginine, loro sali, procedimento per la loro prepara zione e relative composizioni farmaceutiche
IT1219704B (it) Sali di glicosaminoglicani,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1262929B (it) Impiego terapeutico del monosialodiesosil ganglioside gm3 e derivati come agenti anti-angiogenici
EP0301239A3 (en) Use of gepirone for preparing pharmaceutical compositions for alleviation of panic disorders
IT1243702B (it) Composti ad attivita' nootropa, procedimento per la loro preparazione e relative composizioni farmaceutiche
IT8947985A0 (it) Nuovi sali di glicosaminoglicani, procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1231556B (it) Piridine aralchilamminoalchil sostituite in posizione beta, loro sali fisiologicamente accettabili, loro composizioni farmaceutiche, loro uso terapeutico e procedimento per la loro preparazione
IT8721255A0 (it) 2 tiolpropionil arginine, loro sali, procedimento per la loro preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19940330